These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 623907)

  • 1. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C
    Blood; 1978 Mar; 51(3):415-23. PubMed ID: 623907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R; Miller J; Crosby W
    Blood; 1981 May; 57(5):866-72. PubMed ID: 7214016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.
    Rivkin G; Link G; Simhon E; Cyjon RL; Klein JY; Hershko C
    Blood; 1997 Nov; 90(10):4180-7. PubMed ID: 9354689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
    Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of iron chelation in the hypertransfused rat: definition of two alternative pathways of iron mobilization.
    Hershko C; Grady RW; Cerami A
    J Lab Clin Med; 1978 Aug; 92(2):144-51. PubMed ID: 681807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.
    Hershko C; Konijn AM; Nick HP; Breuer W; Cabantchik ZI; Link G
    Blood; 2001 Feb; 97(4):1115-22. PubMed ID: 11159545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferoxamine inhibition of malaria is independent of host iron status.
    Hershko C; Peto TE
    J Exp Med; 1988 Jul; 168(1):375-87. PubMed ID: 3294334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-encapsulated desferrioxamine in experimental iron overload.
    Lau EH; Cerny EA; Rahman YE
    Br J Haematol; 1981 Apr; 47(4):505-18. PubMed ID: 7213574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    J Lab Clin Med; 2001 Aug; 138(2):130-8. PubMed ID: 11477380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation in thalassemia: mechanism of desferrioxamine action.
    Hershko C; Rachmilewitz EA
    Isr J Med Sci; 1978 Nov; 14(11):1111-5. PubMed ID: 750535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine-induced iron excretion in humans.
    Pippard MJ
    Baillieres Clin Haematol; 1989 Apr; 2(2):323-43. PubMed ID: 2660931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.
    Hershko C; Cook JD; Finch DA
    J Lab Clin Med; 1973 Jun; 81(6):876-86. PubMed ID: 4196982
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.
    Octave JN; Schneider YJ; Crichton RR; Trouet A
    Biochem Pharmacol; 1983 Nov; 32(22):3413-8. PubMed ID: 6651865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE; Torrance JD; Bothwell TH; Simon MO; Charlton RW
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of vitamin E on desferrioxamine-induced iron excretion in rats.
    Hershko C; Rachmilewitz EA
    Proc Soc Exp Biol Med; 1976 Jun; 152(2):249-52. PubMed ID: 935189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S; Bomford A
    Biochem J; 1988 Sep; 254(3):869-75. PubMed ID: 3196300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells.
    Link G; Ponka P; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    Blood; 2003 May; 101(10):4172-9. PubMed ID: 12511418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.